View in EDS HTML Full Text PDF Full Text

The recombinant anti-MET/EpCAM bispecific antibody fragment: a promising novel therapeutic approach for breast cancer treatment.

Saved in:
Bibliographic Details
Title: The recombinant anti-MET/EpCAM bispecific antibody fragment: a promising novel therapeutic approach for breast cancer treatment.
Authors: Mirzaei R; Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Azimi M; Department of Biochemistry, Medical Faculty, Saveh Branch, Islamic Azad University, Saveh, Iran., Karimi S; Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran., Karimi MS; Department of Anesthesiology, Pain, and Critical care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Aghel SAM; Department of Molecular and Translational Medicine, Nocivelli Institute for Molecular Medicine, University of Brescia, Brescia, Italy., Salehi M; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Jalili N; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Yadegari F; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Farahmand L; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. laylafarahmand@gmail.com.
Source: Investigational new drugs [Invest New Drugs] 2025 Jun; Vol. 43 (3), pp. 687-700. Date of Electronic Publication: 2025 May 30.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40445574
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The recombinant anti-MET/EpCAM bispecific antibody fragment: a promising novel therapeutic approach for breast cancer treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mirzaei+R%22">Mirzaei R</searchLink>; Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Azimi+M%22">Azimi M</searchLink>; Department of Biochemistry, Medical Faculty, Saveh Branch, Islamic Azad University, Saveh, Iran.<br /><searchLink fieldCode="AU" term="%22Karimi+S%22">Karimi S</searchLink>; Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.<br /><searchLink fieldCode="AU" term="%22Karimi+MS%22">Karimi MS</searchLink>; Department of Anesthesiology, Pain, and Critical care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Aghel+SAM%22">Aghel SAM</searchLink>; Department of Molecular and Translational Medicine, Nocivelli Institute for Molecular Medicine, University of Brescia, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Salehi+M%22">Salehi M</searchLink>; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Jalili+N%22">Jalili N</searchLink>; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Yadegari+F%22">Yadegari F</searchLink>; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Farahmand+L%22">Farahmand L</searchLink>; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. laylafarahmand@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2025 Jun; Vol. 43 (3), pp. 687-700. <i>Date of Electronic Publication: </i>2025 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0646 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40445574
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10637-025-01546-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 687
    Titles:
      – TitleFull: The recombinant anti-MET/EpCAM bispecific antibody fragment: a promising novel therapeutic approach for breast cancer treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mirzaei R
      – PersonEntity:
          Name:
            NameFull: Azimi M
      – PersonEntity:
          Name:
            NameFull: Karimi S
      – PersonEntity:
          Name:
            NameFull: Karimi MS
      – PersonEntity:
          Name:
            NameFull: Aghel SAM
      – PersonEntity:
          Name:
            NameFull: Salehi M
      – PersonEntity:
          Name:
            NameFull: Jalili N
      – PersonEntity:
          Name:
            NameFull: Yadegari F
      – PersonEntity:
          Name:
            NameFull: Farahmand L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-0646
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1